Patterns of psychological distress related to regular methamphetamine and opioid use

Addiction Research and Theory

Volumn 19, Issue 2, 2011, Pages 121-127

  Darke, Shane ^a   Torok, Michelle ^a   McKetin, Rebecca ^a   Kaye, Sharlene ^a   Ross, Joanne ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

heroin; Methamphetamine; polydrug use; psychopathology

Indexed keywords

EID: 79952259814     PISSN: 16066359     EISSN: 14767392     Source Type: Journal    
DOI: 10.3109/16066351003695631     Document Type: Article

References (31)

1. Borges, G., Walters, E. E., & Kessler, R. C. (2000). Associations of substance use, abuse, and dependence with subsequent suicidal behaviour. American Journal of Epidemiology, 151, 781-789. (Pubitemid 30461142)
2. Brienza, R. S., Stein, M. D., Chen, M. H., Cogineni, A., Sobota, M., Maksad, J., & Clark, J. (2000). Depression among needle exchange and methadone maintenance clients. Journal of Substance Abuse Treatment, 18, 331-337. (Pubitemid 30254355)
3. Clark, H. W., Masson, C. L., Delucchi, K. L., Hall, S. M., & Sees, K. L. (2001). Violent traumatic events and drug abuse severity. Journal of Substance Abuse Treatment, 20, 121-127. (Pubitemid 32288843)
4. Conway, K. P., Compton, W., Stinson, F. S., & Grant, B. F. (2006). Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: Results from the national epidemiologic survey on alcohol and related conditions. Journal of Clinical Psychiatry, 67, 247-257. (Pubitemid 43357471)
5. Curran, C., Byrappa, N., & McBride, A. (2004). Stimulant psychosis: Systematic review. British Journal of Psychiatry, 185, 196-204. (Pubitemid 39208220)
6. Dalmau, A., Bergman, B., & Brismar, B. (1999). Psychotic disorders among in-patients with abuse of cannabis, amphetamines and opiates. Do dopaminergic stimulants facilitate psychiatric illness? European Psychiatry, 14, 366-371.
7. Darke, S., Kaye, S., McKetin, R., & Duflou, J. (2008). The major physical and psychological harms of methamphetamine use. Drug and Alcohol Review, 27, 253-262.
8. Darke, S., Mills, K. L., Ross, J., Teesson, M., Williamson, A., & Havard, A. (2009). Patterns of major depression and drugrelated problems amongst heroin users across 36 months. Psychiatric Research, 166, 7-14.
9. Darke, S., & Ross, J. (1997). Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug and Alcohol Dependence, 48, 135-141. (Pubitemid 27466474)
10. Darke, S., Williamson, A., Ross, J., Teesson, M., & Lynskey, M. (2004). Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Dependence, 74, 77-83. (Pubitemid 38457056)
11. Dean, A., Bell, J., Christie, M. J., & Mattick, R. P. (2004). Depressive symptoms during buprenorphine vs. methadone maintenance: Findings from a randomised, controlled trial in opioid dependence. European Psychiatry, 19, 510-513. (Pubitemid 39602776)
12. Derogatis, L. R. (1993). BSI, Brief Symptom Inventory: Administration, scoring, and procedures manual (4th ed.). Minneapolis: National Computer Systems.
13. Dinwiddie, S. H., Cottler, L., Compton, W., & Abdallah, A. B. (1996). Psychopathology and HIV risk behaviours among injection drug users in and out of treatment. Drug and Alcohol Dependence, 43, 1-11. (Pubitemid 26382194)
14. Farrell, M., Boys, A., Bebbington, P., Brugha, T., Coid, J., Jenkins, R., Taylor, C. (2002). Psychosis and drug dependence: Results from a national survey of prisoners. British Journal of Psychiatry, 181, 393-398. (Pubitemid 35333106)
15. Gossop, M., Marsden, J., Stewart, D., & Treacy, S. (2002). Change and stability of change after treatment of drug misuse. 2 year outcomes from the National Treatment Outcome Research Study (UK). Addictive Behaviors, 27, 155-166. (Pubitemid 34003033)
16. Hall, W., Hando, J., Darke, S., & Ross, J. (1996). Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. Addiction, 91, 81-87. (Pubitemid 26026812)
17. Hubbard, R. L., Craddock, S. G., Flynn, P. M., Anderson, J., & Etheridge, R. M. (1997). Overview of one year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviours, 11, 261-278. (Pubitemid 28046589)
18. Jackson, C. T., Covell, N. H., Frisman, L. K., & Essock, S. M. (2004). Validity of self-reported drug use among people with co-occurring mental health and substance use disorders. Journal of Dual Diagnosis, 1, 49-63. (Pubitemid 41232439)
19. Kiddorf, M., Brooner, R. K., King, V. L., Chutuape, M. A., & Stitzer, M. L. (1996). Concurrent validity of cocaine and sedative dependence diagnoses in opioid-dependent outpatients. Drug and Alcohol Dependence, 42, 117-123. (Pubitemid 26312890)
20. Matsumoto, T., Kamijo, A., Miyakawa, T., Endo, K., Yabana, T., Kishimoto, H., Kosaka, K. (2002). Methamphetamine in Japan: The consequences of methamphetamine abuse as a function of route of administration. Addiction, 97, 809-817. (Pubitemid 34729095)
21. McKetin, R., McLaren, J., Lubman, D., & Hides, L. (2006). The prevalence of psychotic symptoms among methamphetamine users. Addiction, 101, 1473-1478. (Pubitemid 44337772)
22. Mills, K., Lynskey, M., Teesson, M., Ross, J., & Darke, S. (2005). Post-traumatic stress disorder among people with heroin dependence in the Australian Treatment Outcome Study (ATOS): Prevalence and correlates. Drug and Alcohol Dependence, 77, 243-249. (Pubitemid 40283526)
23. Nakama, H., Chang, L., Cloak, C., Jiang, C., Alicata, D., & Haning, W. (2008). Association between psychiatric symptoms and craving in methamphetamine users. American Journal on Addictions, 17, 441-446.
24. Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A., & Cooke, R. (2005). The characteristics of heroin users entering treatment: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review, 24, 411-418. (Pubitemid 43024040)
25. Rossow, I., & Lauritzen, G. (2001). Shattered childhood: A key issue in suicidal behavior among drug addicts. Addiction, 96, 227-240. (Pubitemid 32154483)
26. SPSS Inc. (2006). SPSS for Windows, 15.0. Chicago: SPSS Inc.
27. Strain, E. C., Stitzer, M. L., & Bigelow, G. E. (1991). Early treatment time course of depressive symptoms in opiate addicts. Journal of Nervous and Mental Disease, 179, 215-221.
28. United Nations Office of Drug Control (2008). World illicit drug report 2008. New York: United Nations Publications.
29. Welp, E. A., Bosman, I., Langedam, M. W., Totte, M., Maes, R. A., & Van Ameijden, E. J. (2003). Amount of selfreported illicit drug use compared to quantitative hair test results in community-recruited young drug users in Amsterdam. Addiction, 98, 987-994. (Pubitemid 36808265)
30. World Health Organization (1997). Composite international diagnostic interview (version 2.1). Vienna: World Health Organization.
31. Zweben, J. E., Cohen, J. B., Christian, D., Galloway, G. P., Salinardi, M., Parent, D., & Iguchi, M. (2004). Psychiatric symptoms in methamphetamine users. American Journal on Addictions, 13, 181-190. (Pubitemid 38585698)